Date: 2021-08-24
Type of information: Opening of new premises
Compound: new analytical laboratory in Bengaluru, India
Company: Recipharm (Sweden)
Therapeutic area: Technology - Services
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru, India.
The new 370 m2 area is fully cGMP compliant and is equipped with state-of-the-art technology and instruments to cater for the rising demand from customers for the company's stand-alone Recipharm Analytical Solutions™. Recipharm Analytical Solutions™ is designed to help customers with timely, reliable outsourced support for analytical services from concept through to commercial.
The new laboratory will accommodate 40 scientists and will bolster the team's capacity to support additional projects.
Recipharm has also appointed Mr. Manivel Thangapragasam as Associate Director to lead the new laboratory. Manivel brings 21 years of experience in the field of analytical development and stability studies.
The new lab has been in full operation since August 1 2021.
Financial terms:
Latest news:
